Beyond Knowledge: What Truly Drives Innovation in Life Sciences?

Dr Luca Cassetta, VP of Immunology and co-founder of Macomics, reflects on the deeper drivers of innovation in life sciences and the cultural shifts needed to turn discovery into impact.

Innovation in Life Sciences: Beyond Knowledge Alone

Innovation often is associated to images of groundbreaking technologies, transformative medicines, or startups able to disrupt completely a research sector.

But what does drive innovation?

Knowledge alone does not guarantee innovation. History is filled with brilliant ideas that never left the pages of academic journals or the minds of their discoverers. The gap between discovery and real-world application is big, and bridging it requires more than intellectual insight.

Innovation requires entrepreneurial drive, risk-taking, access to networks, investment, and systems that reward translation as much as discovery. Without these ingredients, even the most extraordinary knowledge risks stagnating in isolation.

This tension between knowledge and application is particularly relevant to life sciences, a field where Scotland has long been a leader in academic research. The country is home to world-class universities, cutting-edge labs, and an abundance of scientific talent. In terms of research output and discovery, Scotland punches well above its weight. But when it comes to turning these discoveries into innovative startups, the numbers tell a different story.

The Innovation Paradox in Scotland

Scotland’s life sciences sector has been identified as one of the nation’s key economic strengths. Yet, despite a robust pipeline of research, Scotland consistently produces fewer life science startups than expected given the scale of its academic ecosystem. This paradox, plentiful knowledge but relatively limited innovation, raises an important question: why is groundbreaking research not translating into more commercial ventures?

One major factor lies in the structure of academic incentives. In today’s system, researchers are often rewarded for publishing papers, securing grants, and advancing theoretical understanding. These metrics drive career progression, reputation, and institutional recognition. While this system undeniably fosters world-class research, it inadvertently deprioritizes innovation in its applied form. Creating a startup, developing a product, or navigating regulatory approval does not carry the same weight as publishing in a high-impact journal.

As a result, many academics who might otherwise pursue commercialization find themselves bound to a system that rewards discovery but not application. The cost is significant, not just to individual researchers who see fewer opportunities to diversify their careers, but to Scotland’s economy, which misses out on potential startups that could grow into major employers, attract investment, and deliver societal benefit through new therapies or technologies.

Beyond Discoveries: Building a Culture of Translation

If knowledge alone cannot drive innovation, then the solution lies in fostering an environment that enables and rewards the translation of knowledge into impact. This does not mean diminishing the value of pure academic research but instead rethinking incentives, infrastructure, and support systems so that researchers are encouraged to take the next step beyond discovery.

Scotland has already made progress in this area, with initiatives such as innovation centres, incubators, and translational funding schemes. However, these initiatives alone cannot overcome the structural challenges. What is needed is a cultural shift, one in which entrepreneurial pathways are celebrated within academia, and where the act of starting a company or partnering with industry is seen as equally prestigious as publishing a paper.

Moreover, innovation thrives at the intersections of disciplines and sectors. Life sciences startups often emerge not just from biology, but from the fusion of biology with data science, engineering, or business expertise. Scotland’s universities and innovation hubs could play a stronger role in encouraging cross-disciplinary collaboration and equipping researchers with entrepreneurial skills, from intellectual property management to pitching for investment.

Unlocking Scotland’s Potential

Scotland has the raw ingredients to become a global leader in life sciences innovation: a rich base of knowledge, skilled researchers, and strong international reputation. The challenge is to create pathways that transform knowledge into tangible impact.

If the academic system can evolve to reward not only discovery but also application, and if researchers are supported in taking entrepreneurial risks, Scotland could see a new wave of startups emerge. These companies would not only strengthen the economy but also bring forward innovations with the potential to improve health outcomes worldwide.

In the end, innovation is not about choosing between knowledge and application, it is about recognizing that knowledge is only the starting point. What matters most is how we use it. For Scotland’s life sciences sector, the future lies not just in producing discoveries, but in creating the conditions where those discoveries can become innovations that change lives.

About the author

Dr Luca Cassetta is VP of Immunology and co-founder of Macomics where he applies his deep expertise in human macrophage biology to drive immunology innovation. His pioneering research on Tumor Associated Macrophages and development of the Macomics screening platform earned him the 2019 Innovation Prize Cup as a young biotech entrepreneur.